Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 1.93 | 0.46 | -0.01 | -1.60 |
Depreciation/ Depletion | 0.00 | 0.00 | - | 0.00 |
Changesin Working Capital | 0.04 | 1.25 | 1.41 | 5.55 |
Cashfrom Operating Activities | 1.97 | 1.70 | 1.40 | 3.95 |
Other Investing Cash Flow Items Total | -2.08 | -1.66 | -1.32 | -3.64 |
Cashfrom Investing Activities | -2.08 | -1.66 | -1.32 | -3.64 |
Issuance( Retirement)of Debt Net | 0.00 | 0.00 | 0.00 | -0.31 |
Cashfrom Financing Activities | 0.00 | 0.00 | 0.00 | -0.31 |
Net Changein Cash | -0.11 | 0.05 | 0.08 | 0.00 |
Biogen Pharmachem Industries Dividend Biogen Pharmachem Industries Bonus Biogen Pharmachem Industries News Biogen Pharmachem Industries AGM Biogen Pharmachem Industries Rights Biogen Pharmachem Industries Splits Biogen Pharmachem Industries Board Meetings Biogen Pharmachem Industries Key Metrics Biogen Pharmachem Industries Shareholdings Biogen Pharmachem Industries Profit Loss Biogen Pharmachem Industries Balance Sheet Biogen Pharmachem Industries Q1 Results Biogen Pharmachem Industries Q2 Results Biogen Pharmachem Industries Q3 Results Biogen Pharmachem Industries Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks